ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is a biotech company developing cancer drugs that work against tumors that have become resistant to existing treatments. The company's main experimental drugs target specific mutations in cancer cells: one focuses on certain lung and brain cancers, and another targets prostate cancer. ORIC is testing these drugs in early human trials, sometimes in combination with cancer medicines made by larger pharmaceutical companies like Bayer and Johnson & Johnson. The company was founded in 2014 and is based in South San Francisco.